Tag Archives: Hanmi Pharmaceutical

November, 2015

March, 2015

  • 19 March

    Lilly Partners with Hanmi for Autoimmune Disorder Drug

    Eli Lilly and Company is shelling out up to $690 million for access to Hanmi Pharmaceutical’s Phase I compound HM71224, in development for autoimmune diseases. The companies announced today that they have entered into an exclusive license and collaboration agreement for the development and commercialization of Hanmi’s oral Bruton’s tyrosine …